Antiviral Drugs Market by Application and Geography - Forecast and Analysis 2021-2025

1 Executive Summary

2 Market Landscape

• 2.1 Market ecosystem
  • Exhibit 01: Parent market
  • Exhibit 02: Market characteristics

• 2.2 Value chain analysis
  • Exhibit 03: Pharmaceuticals – Value chain analysis

3 Market Sizing

• 3.1 Market definition
  • Exhibit 04: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
  • Exhibit 05: Market segments

• 3.3 Market size 2020

• 3.4 Market outlook: Forecast for 2020 - 2025
  • Exhibit 06: Global - Market size and forecast 2020 - 2025 ($ billion)
  • Exhibit 07: Global market: Year-over-year growth 2020 - 2025 (%)

4 Five Forces Analysis

• 4.1 Five Forces Summary
  • Exhibit 08: Five forces analysis 2020 & 2025

• 4.2 Bargaining power of buyers
  • Exhibit 09: Bargaining power of buyers

• 4.3 Bargaining power of suppliers
  • Exhibit 10: Bargaining power of suppliers

• 4.4 Threat of new entrants
  • Exhibit 11: Threat of new entrants

• 4.5 Threat of substitutes
  • Exhibit 12: Threat of substitutes

• 4.6 Threat of rivalry
  • Exhibit 13: Threat of rivalry

• 4.7 Market condition
  • Exhibit 14: Market condition - Five forces 2020

5 Market Segmentation by Application

• 5.1 Market segments
  • Exhibit 15: Application - Market share 2020-2025 (%)

• 5.2 Comparison by Application
  • Exhibit 16: Comparison by Application

• 5.3 Hepatitis - Market size and forecast 2020-2025
  • Exhibit 17: Hepatitis - Market size and forecast 2020-2025 ($ billion)
  • Exhibit 18: Hepatitis - Year-over-year growth 2020-2025 (%)

• 5.4 HIV - Market size and forecast 2020-2025
  • Exhibit 19: HIV - Market size and forecast 2020-2025 ($ billion)
  • Exhibit 20: HIV - Year-over-year growth 2020-2025 (%)

• 5.5 Herpes - Market size and forecast 2020-2025
  • Exhibit 21: Herpes - Market size and forecast 2020-2025 ($ billion)
  • Exhibit 22: Herpes - Year-over-year growth 2020-2025 (%)

• 5.6 Influenza - Market size and forecast 2020-2025
  • Exhibit 23: Influenza - Market size and forecast 2020-2025 ($ billion)
  • Exhibit 24: Influenza - Year-over-year growth 2020-2025 (%)

• 5.7 Others - Market size and forecast 2020-2025
  • Exhibit 25: Others - Market size and forecast 2020-2025 ($ billion)
  • Exhibit 26: Others - Year-over-year growth 2020-2025 (%)

• 5.8 Market opportunity by Application
  • Exhibit 27: Market opportunity by Application

6 Market Segmentation by MOA

• 6.1 Reverse transcriptase inhibitors

• 6.2 Protease inhibitors

• 6.3 Entry/fusion inhibitors

• 6.4 Immune system modulators

7 Customer landscape

• 7.1 Customer Landscape

8 Geographic Landscape

• 8.1 Geographic segmentation

• 8.2 Geographic comparison

• 8.3 North America - Market size and forecast 2020-2025

• 8.4 Europe - Market size and forecast 2020-2025

• 8.5 Asia - Market size and forecast 2020-2025

• 8.6 ROW - Market size and forecast 2020-2025

• 8.7 Key leading countries

• 8.8 Market opportunity by geography

9 Drivers, Challenges, and Trends

• 9.1 Market drivers

• 9.2 Market challenges

• 9.3 Market trends

10 Vendor Landscape

• 10.1 Vendor Landscape

• 10.2 Landscape disruption

• 10.3 Competitive Scenario

11 Vendor Analysis

• 11.1 Vendors covered

• 11.2 Market positioning of vendors

• 11.3 AbbVie Inc.

• 11.4 Bristol-Myers Squibb Co.

• 11.5 F. Hoffmann-La Roche Ltd.

• 11.6 Gilead Sciences Inc.

• 11.7 GlaxoSmithKline Plc

• 11.8 Johnson & Johnson

• 11.9 Merck & Co. Inc.

• 11.10 Novartis AG

• 11.11 Pfizer Inc.

• 11.12 Sanofi

12 Appendix

• 12.1 Scope of the report

• 12.2 Currency conversion rates for US$

• 12.3 Research methodology

• 12.4 List of abbreviations